Does read as though the approval covers the sales to 'professional or self test use' 'but I don't know enough about the regulatory structure of the NZ medical device approvals market. TBH I wasn't even aware we made an application to the TGA equivalent in NZ lol.
Though, reading over the announcement of the AccessBio renegotiated supply agreement it does indicate that AT1 has a right to only sell the POC (professional use) RAT in Aus and NZ. This right is not extended to the sales of the 10million self-use tests in the NZ market. See below
- Forums
- ASX - By Stock
- AT1
- Ann: Atomo receives approval for its COVID-19 antigen test in NZ
AT1
atomo diagnostics limited
Add to My Watchlist
0.00%
!
2.0¢

Ann: Atomo receives approval for its COVID-19 antigen test in NZ, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.41M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 2.0¢ | $668 | 33.41K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 405666 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 216582 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 405666 | 0.019 |
9 | 1336834 | 0.018 |
8 | 1589112 | 0.017 |
8 | 1098560 | 0.016 |
8 | 3079350 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 216582 | 1 |
0.021 | 164341 | 3 |
0.022 | 473894 | 2 |
0.023 | 446636 | 3 |
0.024 | 635767 | 3 |
Last trade - 13.23pm 21/07/2025 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |